Search Browse Earnings

iTeos Therapeutics, Inc. — SlamSEC

iTeos Therapeutics, Inc.

Biological Products, (No Diagnostic Substances)·WATERTOWN, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$12.6M

-96.3% YoY

FY 2024

Adj. EBITDA

-$150.2M

-1192.6% margin

FY 2024

Net Income

-$112.6M

-894.3% margin

FY 2024

EPS (Diluted)

-$3.15

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$251.2M

FY 2024

Total Debt

—

Net Cash

$251.2M

FY 2024

Enterprise Value

—

Debt / EBITDA

1.7x

FY 2024

EV / EBITDA

—

Employees

—